HemoGenix Inc. Announces Publication of its White Paper on "Stem Cells and Predictive in Vitro Toxicity Testing"
11/18/2011 9:45:57 AM
More...
|
Vitro Diagnostics (VODG) Launches New Stem Cell Products for Clinical Use & Presents Webinar with HemoGenix Inc.
7/20/2011 8:30:22 AM
More...
|
Vitro Diagnostics (VODG) Expands HemoGenix Inc. Alliance to Include Cell-based Testing for Liver Toxicity
10/19/2010 10:04:00 AM
More...
|
Vitro Diagnostics (VODG) and HemoGenix Inc. Launch New Products at an International Stem Cell Meeting
6/15/2010 10:15:26 AM
More...
|
Vitro Diagnostics (VODG) Forms Strategic Alliance With a Leading Stem Cell Company HemoGenix Inc.
4/28/2010 11:07:13 AM
More...
|
HemoGenix Inc. Receives Issued Patent for its HALO(R) Technology Platform
4/9/2008 10:48:22 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Announces Material Transfer Agreement with HemoGenix Inc.
1/28/2008 9:25:53 AM
More...
|
HemoGenix Inc. Introduces HALO(R)-96 PQR, the First Stem Cell Potency and Release Assay to Incorporate a Reference Standard
12/5/2007 12:56:09 PM
More...
|
HemoGenix LLC Launches HALO(TM) 384HT, The First Ever High Throughput Predictive Stem Cell Hemotoxicity Screening Platform
6/22/2006 1:41:11 PM
More...
|
Platform For Drug Development Screening Will Be Unveiled By HemoGenix LLC At The 44th Annual Meeting Of The Society Of Toxicology In New Orleans, March 6-10, 2004
10/19/2005 5:12:55 PM
More...
|
|